Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5911 AL 5925

Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors

Bolea I, Gella A, Unzeta M.

J Neural Transm (Vienna). 2013 Jun;120(6):893-902. doi: 10.1007/s00702-012-0948-y. Epub 2012 Dec 13.

An overview on potential neuroprotective compounds for management of Alzheimer's disease

Sheikh IA, Ali R, Dar TA, Kamal MA.

CNS Neurol Disord Drug Targets. 2012 Dec;11(8):1006-11. doi: 10.2174/1871527311211080010.

The role of glial cells in Alzheimer disease: potential therapeutic implications

Lopategui Cabezas I, Herrera Batista A, Pentón Rol G.

Neurologia. 2014 Jun;29(5):305-9. doi: 10.1016/j.nrl.2012.10.006. Epub 2012 Dec 14.

Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice

Masciopinto F, Di Pietro N, Corona C, Bomba M, Pipino C, Curcio M, Di Castelnuovo A, Ciavardelli D, Silvestri E, Canzoniero LM, Sekler I, Pandolfi A, Sensi SL.

Cell Death Dis. 2012 Dec 20;3(12):e448. doi: 10.1038/cddis.2012.189.

[Tacrine and its derivatives in the therapy of Alzheimers disease]

Korábečný J, Spilovská K, Benek O, Musílek K, Soukup O, Kuča K.

Ceska Slov Farm. 2012 Oct;61(5):210-21.

Curcuminoids and resveratrol as anti-Alzheimer agents

Villaflores OB, Chen YJ, Chen CP, Yeh JM, Wu TY.

Taiwan J Obstet Gynecol. 2012 Dec;51(4):515-25. doi: 10.1016/j.tjog.2012.09.005.

Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways

Silva T, Teixeira J, Remião F, Borges F.

Angew Chem Int Ed Engl. 2013 Jan 21;52(4):1110-21. doi: 10.1002/anie.201204964. Epub 2012 Dec 20.

[Advance in study on endogenous formaldehyde and pathogenesis of Alzheimer's disease]

Li WW, Guo H, Fan GW, Wang XM.

Zhongguo Zhong Yao Za Zhi. 2012 Oct;37(20):3017-20.

Higher-dose (23 mg/day) donepezil formulation for the treatment of patients with moderate-to-severe Alzheimer's disease

Christensen DD.

Postgrad Med. 2012 Nov;124(6):110-6. doi: 10.3810/pgm.2012.11.2589.

Review of drugs for Alzheimer's disease

Sun X, Jin L, Ling P.

Drug Discov Ther. 2012 Dec;6(6):285-90.

Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia

Nasab NM, Bahrammi MA, Nikpour MR, Rahim F, Naghibis SN.

J Pak Med Assoc. 2012 Jul;62(7):677-80.

Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia

Neri M, Bonassi S, Russo P.

Curr Drug Targets. 2012 May;13(5):636-43. doi: 10.2174/138945012800398928.

The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease

Carroll JC, Rosario ER.

Curr Alzheimer Res. 2012 Jan;9(1):18-34. doi: 10.2174/156720512799015109.

Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up

Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Herrmann FR, Beauchet O.

J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1205-11. doi: 10.1093/gerona/gls107. Epub 2012 Apr 13.

The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design

Andersen F, Viitanen M, Halvorsen DS, Straume B, Wilsgaard T, Engstad TA.

BMC Neurol. 2012 Jul 19;12:59. doi: 10.1186/1471-2377-12-59.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias